Hims & Hers Health HIMS
NYSE HIMS
$32.15 +1.06 (+3.43%)
As of: Aug 20, 2026 · 3:54 PM EDT

Hims & Hers Health (HIMS) Total Non-Current Liabilities (2020 - 2026)

Hims & Hers Health (HIMS) posted Total Non-Current Liabilities of $1.8 billion for Q1 2026, up 12.85% sequentially from $1.6 billion in Q4 2025, and up 431.74% YoY from $340.0 million in Q1 2025.

Hims & Hers Health (HIMS) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Hims & Hers Health has reported Total Non-Current Liabilities for 7 years, with the latest figure at $1.8 billion in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 431.74% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 431.74% YoY) and the FY2025 annual result came in at $1.6 billion, up 594.06% from the prior year.
  • Total Non-Current Liabilities climbed to $1.8 billion in Q1 2026 per HIMS's latest filing, from $1.6 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.8 billion in Q1 2026 and troughed at $53.8 million in Q1 2022.
  • A 5-year average of $463.6 million and a median of $103.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities slumped 36.06% in 2022, then soared 1008.31% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $54.6 million in 2022, then surged by 78.02% to $97.1 million in 2023, then soared by 137.63% to $230.8 million in 2024, then soared by 594.06% to $1.6 billion in 2025, then increased by 12.85% to $1.8 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.8 billion, $1.6 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - 334.00 Mn
10 Hims & Hers Health 7.44 Bn 6.60 Bn 480.80 Mn 3.30 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.30 Bn
Mar 31, 2026 1.81 Bn
Dec 31, 2025 1.60 Bn
Sep 30, 2025 1.65 Bn
Jun 30, 2025 1.31 Bn
Mar 31, 2025 340.01 Mn
Dec 31, 2024 230.82 Mn
Sep 30, 2024 162.21 Mn
Jun 30, 2024 118.51 Mn
Mar 31, 2024 103.60 Mn
Dec 31, 2023 97.14 Mn
Sep 30, 2023 85.30 Mn
Jun 30, 2023 69.81 Mn
Mar 31, 2023 63.48 Mn
Dec 31, 2022 54.57 Mn
Sep 30, 2022 71.63 Mn
Jun 30, 2022 60.54 Mn
Mar 31, 2022 53.81 Mn
Dec 31, 2021 85.34 Mn
Sep 30, 2021 53.72 Mn